Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Leukemia·2026
Same author

Revisiting Clonal Evolution Through the Light of Retrotransposons.

BioEssays : news and reviews in molecular, cellular and developmental biology·2025
Same author

Applying multilevel selection to understand cancer evolution and progression.

PLoS biology·2025
Same author

Epistemic limitations of measurable residual disease in haematological malignancies.

The Lancet. Haematology·2025
Same author

Monocytes generated by interleukin-6-treated human hematopoietic stem and progenitor cells secrete calprotectin that inhibits erythropoiesis.

iScience·2025
Same author

Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Communications biology·2024
Same journal

"Wouldn't It Be Easier to Be Burned at the Stake?": Schizophrenia and Deinstitutionalization in <i>Bitter Medicine</i>.

Perspectives in biology and medicine·2026
Same journal

The Mental Health Crisis of Rural America: Understanding Supply and Demand.

Perspectives in biology and medicine·2026
Same journal

The Final Act of Care: Accuracy in Cause of Death Statements.

Perspectives in biology and medicine·2026
Same journal

Existential Competence: Redefining Clinical Excellence Beyond Health Optimization.

Perspectives in biology and medicine·2026
Same journal

Making Fun of Medicine: Resisting Medicine's Principalities.

Perspectives in biology and medicine·2026
Same journal

Courage, Conviction, Resolve: The Story of Dr. Gui Xi'en.

Perspectives in biology and medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

Reprogramming and Stemness.

Lucie Laplane

    Perspectives in Biology and Medicine
    |January 12, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Cellular reprogramming challenges the idea that cell differentiation is permanent. This study explores the biological and philosophical nature of stemness and its implications for cancer therapies.

    More Related Videos

    Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
    09:34

    Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

    Published on: November 27, 2017

    9.9K
    Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
    08:56

    Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

    Published on: July 30, 2016

    7.0K

    Related Experiment Videos

    Last Updated: Mar 27, 2026

    Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
    07:08

    Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

    Published on: February 2, 2024

    1.6K
    Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
    09:34

    Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

    Published on: November 27, 2017

    9.9K
    Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
    08:56

    Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

    Published on: July 30, 2016

    7.0K

    Area of Science:

    • Cell Biology
    • Developmental Biology
    • Philosophy of Science

    Background:

    • Classical cell differentiation was considered a one-way, irreversible process.
    • Recent reprogramming technologies demonstrate the plasticity of cellular identity.
    • This challenges fundamental concepts in developmental biology.

    Purpose of the Study:

    • To philosophically and biologically define 'stemness'.
    • To explore the implications of reprogramming for stem cell biology.
    • To examine the consequences for scientific research, including anti-cancer therapies.

    Main Methods:

    • Philosophical analysis of cellular identity and stemness.
    • Biological review of reprogramming technologies and stem cell properties.
    • Case study application to anti-cancer therapies.

    Main Results:

    • Stemness is not a fixed, intrinsic property but a dynamic state.
    • Reprogramming blurs the lines between differentiated cells and stem cells.
    • Understanding stemness is crucial for developing targeted cancer treatments.

    Conclusions:

    • Cellular identity is more malleable than previously thought.
    • The concept of stemness requires re-evaluation in light of reprogramming.
    • This has significant potential impacts on regenerative medicine and oncology.